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1. Introduction
As thoracic surgery evolved, anesthesia evolved in parallel, allowing even the most compli‐
cated surgical procedures to be performed relatively safely. This co-evolution mirrors the close
association of the thoracic surgeon and anesthesiologist when caring for their patients. This
unique association is predicated on the nature of thoracic procedures, where the surgeon and
anesthesiologist share a “thoracic workspace” - the surgeon operating on vital thoracic
structures and the anesthesiologist managing ventilation, oxygenation, and hemodynamics.
Because of this close partnering, it is valuable for thoracic surgeons to be familiar with
anesthetic considerations exclusive to their patients.
2. Considerations for One-Lung Ventilation (OLV)
Thoracic Surgery poses unique challenges to the anesthesiologist, including surgery in the
lateral decubitus position, an open thorax, manipulation of thoracic organs, potential for major
bleeding, and, unique among all potential surgery scenarios, the need for lung isolation.
2.1. Physiologic effects of lung isolation
Successful lung isolation (one-lung ventilation, OLV) requires the management of oxygena‐
tion, ventilation, and pulmonary blood flow. Remarkably, OLV decreases total minute
ventilation minimally. In fact, it has been shown that the non-isolated lung receives close to
the same minute ventilation as ventilation to two lungs. The rate of CO2 elimination undergoes
minimal changes because CO2 is readily diffusible and has no plateau in its dissociation curve.
© 2013 Tsai et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
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When a patient is placed on OLV, inevitably a shunt is developed. The non-dependent lung
is no longer being ventilated but is still perfused, resulting in a right to left shunt. When this
occurs, the pulmonary system has physiological adaptations to decrease this shunt. Given that
the patient is in the lateral decubitus position, one of the responses is a decrease in blood flow
to the non-dependent lung due to gravitational forces. These effects are significant because the
pulmonary system has a much lower blood pressure than the systemic circulation. Another
adaptation is hypoxic pulmonary vasoconstriction of the vascular supply in the non-depend‐
ent lung. Hypoxic pulmonary vasoconstriction is a physiological phenomenon in which
pulmonary arteries constrict in the presence of hypoxia (unlike the systemic circulation),
redirecting blood flow to the dependent lung. Surgical compression of the non-dependent lung
can also serve as a way of decreasing shunt as the pulmonary vasculature is compressed. One
last factor contributing to a decrease in shunt fraction is apneic oxygenation—residual oxygen
in the non-dependent isolated lung diffusing into the pulmonary circulation. All these factors
combined allow for better oxygenation during OLV.
2.2. Preoperative anesthetic evaluation of the thoracic surgery patient
Patients undergoing OLV should undergo a perioperative assessment of their respiratory
function that includes testing of lung mechanical function, pulmonary parenchymal function,
and cardiopulmonary reserve. The best assessment of respiratory function comes from a history
of the patient’s quality of life [1]. It is useful to think of respiratory function in three related but
independent areas: respiratory mechanics, gas exchange, and cardio-respiratory interaction [2].
The most valid test for perioperative assessment of respiratory mechanics is the predicted post-
operative forced expiratory volume in one second (ppoFEV1). This test is the best at predicting
post thoracotomy respiratory complications [3].
Percentage of predicted postoperative (ppo) FEV1 after lobectomy is given by
ppoFEV 1= preoperative FEV 1 x No. of  segments  remainingtotal  No. of  segments
Nakahara et al found that patients with a ppoFEV1 of more than 40% had no or only minor
post resection respiratory complications [4]. Major respiratory complications were only seen
in the sub group with ppoFEV1 < 40%; post-operative mechanical ventilator support was seen
in those < 30%.
For the assessment of lung parenchymal function, the most useful test of the gas exchange
capacity is the diffusing capacity for carbon monoxide (DLCO). This test correlates with the
total functioning surface of the alveolar-capillary interface. The DLCO is used to calculate a
post resection value using the same calculation as FEV1. A ppoDLCO less than 40% of
predicted correlates with increased cardiac and respiratory complications and is relatively
independent of the FEV1 [5].
Stair climbing is the most traditional test of respiratory function in the assessment of cardio‐
pulmonary interaction. Ability to climb three flights or more is closely associated with a
decrease in morbidity and mortality. The ability to climb fewer than two flights is associated
with a very high risk [6]. The “gold standard” for assessment is formal laboratory exercise
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testing with maximal oxygen consumption. Climbing five flights of stairs approximates a
VO2 max value of >20 ml/kg/min and less than one flight is associated with values <10 ml/kg/
min (S9). Ventilation-perfusion (V/Q) scintigraphy can also be used as a preoperative assess‐
ment when pulmonary resection is to be undertaken. This modality is particularly helpful for
patients undergoing pneumonectomy or any patient with a ppoFEV1 less than 40% [2].
Slinger et al. proposed a “3-legged” stool of pre-thoracotomy respiratory assessment, which
encompasses the prior mentioned pre-operative tests [7]. This model summarizes the results
of those tests and reveals that patients have lower expected post-operative morbidity if they
have a ppoFEV1 > 40%, cardio-pulmonary reserve with a VO2 max >15 ml/kg/min, and lung
parenchymal function with a ppoDLCO >40%. These three tests are the most valid for pre-
operative assessment. Other tests that can be used are maximal volume ventilation (MVV),
residual volume/total lung capacity (RV/TLC), and forced vital capacity (FVC), but these are
less valid for respiratory mechanics. Stair climbing (two flights), a 6-minute walk, and
measurement in the change in SpO2 (<4%) during exercise are other tests that can be used to
measure cardio-pulmonary reserve. Measurement of arterial blood gas values can also serve
as a respiratory assessment; indicators of good prognosis are PaO2 > 60 and a PaCO2 < 45.
In regards to post-thoracotomy anesthetic management, Slinger et al. devised an algorithm
derived from pre-operative assessment using ppoFEV1 [7]. If the patient’s ppoFEV1 is > 40%
and the patient is awake, alert, warm, and comfortable, immediate postoperative extubation
is recommended. If the ppoFEV1 is between 30-40%, extubation should be considered based
on exercise tolerance, DLCO, V/Q scan, and associated diseases. If the ppoFEV1 < 30%, staged
weaning from mechanical ventilation is recommended. However, when the patient has a
functioning thoracic epidural catheter providing adequate analgesia, extubation may be
attempted even at ppoFEV1 values as low as 20% [7].
2.3. Tracheo-bronchial anatomy for lung isolation
Knowledge of tracheo-bronchial anatomy is important for achieving and maintaining proper
lung isolation. Other chapters in this text describe lung and bronchial anatomy in detail.
Features of the anatomy that are relevant to anesthetic considerations are presented here.
A critical landmark when placing lung isolation devices is the primary carina, where the
trachea splits into two main bronchi. The diversion angle differs between these main bronchi,
with the right bronchi angled at 25 degrees and the left bronchus at 45 degrees. Because of the
steeper angle of diversion of the right main bronchus, foreign bodies (including lung isolation
devices) are more likely to travel into this bronchus. Left and right side double lumen tubes
(DLTs) are designed with curvatures to accommodate left or right main bronchi diversion
angles to make intubation into the specified main bronchi easier (Figure 1).
Because of the steeper angle of the right mainstem bronchus, it is not uncommon to inadver‐
tently intubate the right mainstem when intending to intubate the left mainstem with a DLT
(using blind or non fiberoptic guided placement techniques). Operators unfamiliar with distal
bronchial anatomy sometimes confuse secondary carinas with the primary carina. For
example, the right main bronchus divides at the secondary carina into the upper lobar
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bronchus and bronchus intermedius; this secondary carina may be mistaken for the primary
carina when viewed under bronchoscopy. Therefore, knowledge of distal bronchial anatomy
is fundamental in confirming correct placement as well as in correcting misplacement.
Knowledge of distal bronchial anatomy is essential for additional reasons. First, the operator
must recognize that a right DLT has an additional slot to allow for ventilation of the right upper
lobe and must place it at the correct depth and rotational alignment to assure adequate
ventilation of all three lobes. Secondly, anatomy is abnormal in a small percentage of patients.
For example, in up to 2% of patients, the right bronchus originates directly from the supra
carinal trachea (a so-called bronchus suis) [8]. Abnormal anatomy is also seen in patients who
have had previous lung surgeries. The operator must be able to recognize and respond to
abnormal anatomy by selecting the appropriate device to provide effect lung isolation in any
scenario.
2.4. Indications for lung isolation
Patient pathology and/or operative requirements determine the indication for OLV. Patients
with lung pathology may need lung protection. For example, OLV may be used to protect the
unaffected lung from contamination with pus or blood from the affected lung. Alternatively,
OLV may be used to provide differential lung ventilation to minimize volutrauma and
barotrauma to the affected lung while optimizing ventilation to the non-affected lung. Certain
operative scenarios require OLV. Because it optimizes visualization of the operative site, OLV
is absolutely indicated in closed procedures (for example, thoracoscopic surgery) but is also
useful in open procedures to maximize exposure.
2.5. Lung isolation devices
Three standard methods for lung isolation include DLT, bronchial blockers, and mainstem
intubation.
Figure 1. Left (top) and right (bottom) conformations of double lumen tubes. Note the right upper lobe ventilation
lumen on the right conformation tube.
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2.5.1. DLT
The standard device for providing lung isolation is the DLT. It provides reliable lung isolation,
offers the ability to suction both lungs, allows for bilateral differential lung ventilation with
minimal device manipulation, and allows for simple procedures such as bronchoalveolar
lavage. DLTs range in size from 28 to 41 Fr. Posteroanterior (PA) chest x-ray is the standard
method for sizing comparison between DLT, trachea, and bronchial diameter [9]. However,
patient sex, age, and height are commonly used to choose DLT size. As discussed above, DLTs
are made in right-side and left-side conformations to accommodate the differences in the
anatomy of the right and left main bronchi (i.e., the right upper lobe branch).
2.5.2. SLT with bronchial blocker
Bronchial blockers used with conventional single lumen tubes have advantages in difficult
airways, in patients with indwelling endotracheal or tracheostomy tubes, in patients who are
nasally intubated with SLTs, and in cases where sub-segmental blockade may be required [10].
Bronchial blockers have several disadvantages, however. They are easier to displace and
provide limited suction and drainage to the isolated lung, which may lead to an accumulation
of pus, blood or secretions [11]. They are deployed in the operative lung, which may interfere
with the surgical procedure, and the device must be repositioned for contralateral lung
isolation.
Despite their specific enhancements, bronchial blockers are essentially modeled after vascular
embolization catheters (albeit with high compliance low pressure cuffs and a deflation port).
They are manufactured as separate units or units integrated with an endotracheal tube.
Separate units include the Cohen Flexi-tip BB (Cook Critical Care), Fuji Uni-blocker (Fuji
Systems, Tokyo) (Figure 2A) and the Arndt wire-guided BB (Cook Critical Care, Bloomington,
IN) (Figure 2B). An example of an integrated unit is the Univent tube (Fuji Systems, Tokyo).
2.5.3. Mainstem intubation
Mainstem bronchial intubation with an SLT may be used for lung isolation in emergent
scenarios or in pediatric cases. However, with this method, exhalation of the operative lung is
limited, airway protection at the vocal cords is compromised, and the endotracheal tube tip is
advanced into the operative lung; lastly, repositioning is required if contralateral isolation is
needed. Furthermore, standard endotracheal tubes may be too short to effectively mainstem
intubate either main bronchi; specialized longer tubes, such as Micro Laryngoscopy Tubes
(MLTs), may be required.
2.6. Difficult airway and lung isolation
Campos describes two categories of patients at risk for difficult intubation during OLV: those
with complications related to the upper airway and those related to the lower airway [12]. The
former include a short neck and increased neck circumference, prominent upper incisors with
a receding mandible, limited cervical mobility, limited jaw opening due to previous surgery,
radiation therapy of the neck, previous hemiglossectomy or hemimandibulectomy, and
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tumors of the upper airway. Lower airway risk factors include an existing tracheotomy, a
distorted tracheobronchial anatomy, and compression at the entrance of the left mainstem
bronchus. Patients with any of the above conditions might pose a difficulty for lung isolation
with a conventional DLT and might be candidates for SLT placement with subsequent lung
isolation with a bronchial blocker. However, if a DLT is indicated, fiberoptic intubation may
be used to facilitate placement [13]. However, because of the long length of the DLT, it is
difficult to maintain distal control of the fiberscope, especially with patients having longer oral
to vocal cord distance. Additionally, the small diameter bronchoscope required (to assure fit
for the DLT) results in an inferior view and restricts suction capabilities. Therefore, new
generation indirect laryngoscopes may be preferable. Indirect laryngoscopes (e.g., CMAC
[Storz, Tuttlingen, Germany], GlideScope [Verathon,Bothell, WA], Airtraq (Prodol Meditec
S.A., Vizcaya, Spain)) improve airway grade and have been shown to improve the ease of
intubation with DLTs in patients with difficult airways [14].
2.7. Confirming proper lung isolation
Regardless of the device used for lung isolation, the anesthesiologist must confirm correct
placement of the device. Chest auscultation has traditionally been used to confirm correct DLT
placement. The process is straightforward in patients with normal pulmonary anatomy. First,
inflate both tracheal and bronchial balloons and auscultate to confirm bilateral breath sounds
(if bilateral breath sounds are absent, suspect malposition – the DLT may be too deep). Next,
 
(a) 
(b) 
Figure 2. Examples of bronchial blockers. (A) Fuji Uni-blocker (Fuji Systems, Tokyo); (B) Arndt wire-guided BB (Cook
Critical Care, Bloomington, IN).
Principles and Practice of Cardiothoracic Surgery8
sequentially clamp the tracheal and bronchial inflow limbs of the DLT and auscultate the chest.
Absent breath sounds corresponding to the tracheal or bronchial lumen clamped, should be
confirmed. Different malposition scenarios may be deduced depending on type of DLT (L v.
R), intended mainstem to be intubated, DLT lumen occluded and the absence or presence of
breath sounds. Although auscultation is an important tool in situations where fiberoptic
bronchoscopy is unavailable, studies have shown a large margin of positioning error when it
is not used [15-18]. Fiberoptic confirmation is required for proper positioning of bronchial
blockers because they lack basic ergonomic design features that enable blind placement (like
curvature or specialized ventilation port configurations of DLTs). Furthermore, because
malpositioned lung isolation devices may be potentially be fatal, and auscultation is usually
not an option intraoperatively, fiberoptic bronchoscopy has become the standard for proper
placement and maintenance of lung isolation devices.
3. Intraoperative care for the thoracic surgical patient
3.1. Ventilator strategies for one-lung ventilation
For thoracic surgery, the incidence of pulmonary complications now out-numbers that of
cardiovascular complications [19], and pulmonary complications are the most common cause
of postoperative death in esophageal cancer patients [20]. Injury from one-lung ventilation
(OLV) can manifest as re-expansion pulmonary edema (REPE), acute lung injury (ALI), or
acute respiratory distress syndrome (ARDS). While late causes of ALI (3-10 days after surgery)
are secondary to bronchopneumonia or aspiration, early ALI is predicted by high intraoper‐
ative ventilation pressures, increased surgery duration, excessive intravenous volume
replacement, pneumonectomy, and preoperative alcohol abuse [21]. Most likely, a combina‐
tion of a patient’s health status, intraoperative fluid management, the use of epidural analgesia,
inflammatory responses due to surgical manipulation, alveolar recruitment, and reexpansion/
reperfusion lung injury [22, 23] underlie the development of ALI following OLV [24]. While
chronic patient risk factors are difficult to modify, protective ventilatory strategies and
judicious fluid use may decrease the incidence of ALI [21].
Prior ventilatory schemes focused on the detrimental effects of atelectasis, primarily increased
pulmonary shunt via local alveolar hypoxia and hyperoxia. Tidal volumes of 10-12mL/kg were
advocated, as it was previously held that tidal volumes <8mL/kg resulted in decreased
functional residual capacity (FRC) and worsening atelectasis in the dependent lung. The lowest
positive end-expiratory pressure (PEEP) for acceptable oxygenation and normal arterial CO2
levels (35 to 38 mmHg) were suggested [24]. OLV was achieved with parameters similar to
two-lung ventilation, with consequent stimulation of stretch-activated cation channels,
oxygen-derived free radicals, activated neutrophils, and cytokine upregulation contributing
to increased microvascular-alveolar permeability [25].
The current strategy to minimize OLV-associated lung injury utilizes so-called lung protective
ventilation. Overdistension (volutrauma), excessive transpulmonary pressure resulting in
barotrauma, repeated opening and closing of alveoli resulting in ateletotrauma, and biotrauma
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caused by inflammatory mediators are considered contributing factors to ventilator-induced
lung injury (VILI). These factors combined may induce inflammatory changes in pulmonary
alveolar and vascular endothelium, predisposing them to pathological apoptosis and necrosis.
In this way, VILI can both exacerbate existing lung injury and sensitize the lung to further
injury via a two-hit model [26]. Reduction of tidal volumes during OLV to 5ml/kg was shown
to reduce alveolar concentration of TNF-α and sICAM-1 [27] (will it be obvious to the reader
what implications this has?). Moreover, with fixed tidal volumes of 9mL/kg, the addition of
5cm H2O PEEP was associated with better oxygenation and earlier extubation [28]. PEEP
improves the (ventilation:perfusion) V:Q relationship via increased FRC at end expiration.
However, excessive PEEP may redistribute blood flow away from the dependent ventilated
lung. Thus, protective ventilation consists of:
• maintaining the fraction of inspired O2 (Fi02) as low as possible to avoid absorption atelec‐
tasis and worsening shunt [29]
• PEEP above the lower inflection point on the static pressure-volume curve
• a tidal volume of 5-6 mL/kg, plateau pressures of less than 20 cm H2O above the PEEP value
• peak inspiratory pressures less than 35 cm H2O
• respiratory rate (RR) 10-18
• inspiratory:expiratory (I:E) ratio 1:2 to 1:3
• permissive hypercapnia
• preferential use of pressure-limited ventilatory modes [24].
Hypoxemia may require continuous positive airway pressure (CPAP) to the nondependent
lung, allowing apneic oxygenation and increasing overall partial pressure of O2 (pa02).
Permissive hypercapnia is generally tolerated with protective ventilator strategies during
OLV. Not only does hypocapnia worsen parenchymal and ischemia-reperfusion injury [30],
but hypercapnia itself may have beneficial effects on serum cytokine levels, apoptosis, and free
radical injury [31]. The optimal level of paCO2 has not been determined.
Pressure controlled ventilation achieves lower airway pressure, and the homogeneous
distribution of inspired gas allows recruitment of collapsed lung and improved oxygenation
[32]. This method is thought to minimize end-inspiratory distension and collapse of lung units
and has demonstrated a decreased inflammatory response, improved lung function, and
earlier extubation [28]. As compared with conventional ventilation, this protective strategy
was associated with improved survival at 28 days, a higher rate of weaning from mechanical
ventilation, and a lower rate of barotrauma in patients with ARDS. However, protective
ventilation was not associated with a higher rate of survival to hospital discharge [25]. Even
with protective lung ventilatory strategies, it is possible that certain patchy segments of alveoli
are intermittently and inconsistently recruited, resulting in impaired surfactant effectiveness
and barotrauma.
Lung protective ventilation primarily refers to the dependent lung, which shows a more
pronounced inflammatory response than the nonventilated lung [33, 34]. However, it is likely
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that the overall postoperative clinical picture amounts to the combination of differing insults
to the operative and nonoperative lung. Hypoxia-induced lung inflammation [30] and stress-
induced mechanical injury affects the operative lung as well, as the atelectatic, nonventilated
lung is periodically inflated to assess air leaks. Additionally, the operative lung is subject to
pulmonary contusion due to surgical manipulation and mechanical trauma. After 30 minutes
of OLV, the collapsed lung releases inflammatory mediators into the epithelial lining fluid,
indicating tissue insult and possibly resulting in systemic physiological changes [35]. Finally,
barotrauma may occur at the end of OLV as previously atelectatic alveolar units are recruited.
The contribution of the type of anesthetic to the inflammatory response and clinical outcomes
is currently unknown. Studies comparing propofol to volatile anesthetics such as sevoflurane
and desflurane have yielded conflicting results [36]. Overall, differences in surgical time,
duration of OLV, and laboratory techniques in existing studies have complicated interpreta‐
tion of the data[24]. Volatile agents are thought to have immune-modulating effects. While
previous work showed anti-inflammatory effects of propofol, recent studies have demon‐
strated decreased inflammatory markers in both the operative and nonoperative lung with
volatile anesthesia[36-38]. Sugasawa and colleagues found that sevoflurane use was signifi‐
cantly associated with a suppressed inflammatory response compared to propofol [38]. Thus,
the choice of anesthetic agent and other drugs such as ropivacaine, ketamine, thiopental, and
dexmedetomidine may have anti-inflammatory effects that may be protective during lung
surgery with OLV. Further study is needed to elucidate the role of these agents [39].
In conclusion, lung protective ventilator strategies which minimize Fi02, barotrauma, and
volutrauma are currently being used during OLV. Optimal lung protection, however, is
multifactorial and may also depend on fluid administration techniques and perioperative drug
administration. Alternative lung protective strategies for experimental or rescue use, such as
extracorporeal membrane oxygenation and high-frequency oscillatory ventilation are dis‐
cussed elsewhere.
3.2. Fluid therapy — Goal directed therapy for thoracic surgery
Intravenous fluids are administered perioperatively in order to optimize systemic oxygen
delivery to meet metabolic demands. Cardiac preload, afterload, and contractility are fre‐
quently used as surrogate indicators of global tissue perfusion. Inadequate intravascular
volume can predispose to ischemia and end-organ dysfunction. Excessive fluid administra‐
tion, on the other hand, can lead to tissue edema and compromised perfusion. In the operative
setting, surgical insults may theoretically cause an inflammatory response characterized by
alterations in microvascular integrity, allowing abnormal transmicrovascular fluid flux. Due
to this increase in microvascular permeability, interstitial edema may develop, which decreas‐
es O2 diffusion, resulting in hypoxic cell injury. This injury propagates a vicious cycle involving
further cell death and the subsequent release of inflammatory cytokines.
In  esophagectomy patients,  the  goal  of  intraoperative  fluid  administration  is  to  balance
perfusion pressure and oxygen delivery to vital  organs including the gut mucosa, while
preventing  excessive  fluid  accumulation  that  may  delay  recovery  of  gastrointestinal
function, impair wound and anastomotic healing, coagulation, and cardiac and respirato‐
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ry  function.  Restrictive  fluid  regimens  were  thought  to  result  in  better  gastrointestinal
recovery time, reduced overall morbidity[40], improved respiratory parameters, decreased
incidence  of  postoperative  pulmonary  complications,  and  shorter  recovery  periods  [41].
Conversely, fluid overload had a direct negative relationship to function and structure of
the intestinal anastomoses [42].
The thoracic surgery population is particularly prone to pulmonary complications, which have
significant implications for patient outcomes. In the setting of pulmonary resection, for
example, postoperative pulmonary edema confers a high mortality risk. Three significant risk
factors include right pneumonectomy, increased perioperative intravenous fluids, and
increased postoperative urine output [43]. Patel (1992) found that fluid replacement of greater
than 3L in the 24 hours surrounding surgery was correlated with increased mortality [44].
While pulmonary edema is associated with fluid overload, there is no clear causal relationship
[45]. With histology compatible with ARDS, postpneumonectomy pulmonary edema occurs
despite a normal PAOP, and the high protein content of edema fluid points toward low-
pressure endothelial damage[46]. Nevertheless, appropriate fluid administration may mitigate
the deleterious effects of pulmonary pathology.
Traditional static cardiac preload measures such as CVP may fail to provide reliable estima‐
tions of actual preload and cardiac responses to fluid therapy. Studies on supine patients have
demonstrated improved intraoperative hemodynamic stability, reduced ICU admissions,
lower incidence of complications, and reduced mortality after major surgery with the use of
dynamic preload indicators and goal-directed fluid therapy (GDT) [47, 48]. Commonly used
monitors include esophageal Doppler monitoring and measures of arterial pulse pressure
variation with respiration, such as the Lithium Dilution Cardiac Output (LiDCOplus) system
and FloTrac/Vigileo. Using an esophageal Doppler probe, Gan (2002) found that GDT in
patients undergoing major elective general, urologic, or gynecologic surgery with an antici‐
pated blood loss of greater than 500mL resulted in an earlier return of bowel function, lower
incidence of postoperative nausea and vomiting, and decreased length of postoperative
hospital stay [49].
GDT does not consistently result in either increased or decreased amounts of fluid adminis‐
tered. One study[50] showed that the GDT group received more volume. However, in a cohort
of septic patients, GDT patients received significantly more fluid during the first six hours than
those assigned to standard therapy; but in the overall period from baseline to 72 hours after
the start of treatment there was no significant difference between the two groups in the total
amount of fluid administered. Early GDT provided significant outcome benefits: of the patients
who survived to hospital discharge, those assigned to standard therapy had significantly
longer hospital stays than those with early GDT[51].
Slinger describes one rational approach to fluid administration [45]. The thorax is not assumed
to be a third space. Total positive fluid balance in the first 24 hours postoperatively should not
exceed 20ml/kg or approximately 3L of crystalloid. Unless the patient is at high risk of
developing renal insufficiency, urine output of greater than 0.5mL/kg/hr is probably unnec‐
essary. In the case of reduced tissue perfusion, as in the case of epidural-induced sympathec‐
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tomy, it is preferable to invasively monitor and use GDT. The use of inotropes may be
preferable to aggressive fluid overload.
One limitation of GDT, however, involves the extrapolation of studies correlating cardiac
output measurements via PACs with those obtained via dynamic indices during abdominal
surgery to thoracotomy patients who are positioned laterally and subjected to varying
intrathoracic conditions, such as exposure to atmospheric pressure and OLV. The value of
dynamic preload indicators in the thoracic population has not been systematically examined.
Possible problems with extending the use of this device to thoracic surgery patients include
lung compliance and intrathoracic pressure variations during positioning changes or insuf‐
flation for RATS, laparoscopy and changing intraabdominal pressure, the open chest, pressure
changes with VATS, and differing ventilatory settings (TV, PEEP, OLV, DLV). One study has
shown that GDT is at least not deleterious or does not result in pulmonary fluid overload when
used for thoracic surgery requiring lateral thoracotomy and OLV[52]. While changing from
the supine to the reverse Trendelenburg or prone positions significantly alters SV and thus
SVV, 30° left or right recumbent and supine positions do not appear to affect SV or SVV
measurements [53]. Kobayashi concludes that SVV, as displayed on the Vigileo monitor, is
considered an accurate predictor of intravascular hypovolemia and is a useful indicator for
assessing the appropriateness and timing of applying fluid for improving circulatory stability,
but only during the perioperative period after esophagectomy [54]. De Waal (2002) demon‐
strated that while PiCCO-derived dynamic preload indicators were able to predict fluid
responsiveness under closed-chest conditions, both static and dynamic preload indicators
failed to predict fluid responsiveness in open-chest conditions [55]. Stroke volume variation
(SVV) and pulse pressure variation (PPV) seem to be critically dependent on the undisturbed
transmission of these pressure changes to cardiovascular structures within the closed thorax
[56]. For example, sternotomy alone decreases SVV [57]. Additionally, one study [58] found
that SVV could predict fluid responsiveness in patients undergoing OLV with acceptable levels
of sensitivity and specificity only when tidal volumes were at least 8mL/kg. They state that
dynamic indices of preload are based on the concept that positive pressure ventilation induces
variations in SV. By definition, this concept requires that the preload is significantly affected
by cyclic changes in intrathoracic and transpulmonary pressures, and these changes may be
too small when patients undergoing OLV are ventilated with low tidal volumes (i.e. 6mL/kg).
In short, the ability of SVV to predict volume responsiveness in thoracotomy patients is
currently unknown.
Finally, the optimal type of fluid is debatable. Some animal models have demonstrated greater
interstitial edema with crystalloid administration and better preserved effective capillary
cross-sectional area in the colloid group[59]. Other studies conclude that when given in similar
volumes, colloids are more beneficial for anastomotic healing than crystalloid [24, 42].
Improved microcirculatory blood flow and tissue oxygen tension were observed after ab‐
dominal surgery in one animal model [60, 61]. However, no difference in anastomotic healing
was found in another animal model of colloid use [62]. To date, no consensus has been reached
as to the superiority of crystalloids versus colloids. Pulmonary edema due to excessive
crystalloid may clear faster than that caused by colloids.
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In summary, intelligent fluid administration is vital to maintaining tissue perfusion and
minimizing edema in the perioperative period. New methods of GDT based on SVV may offer
useful tools to guide clinicians during thoracic surgery cases. However, the applicability of
this technology to the thoracic population has not been fully investigated. Most likely, avoiding
fluid overload by tailoring GDT in an educated manner to the patient’s specific deficit and
type of fluid loss yields optimal results.
3.3. Special intraoperative monitoring
Since thoracic surgery involves hemodynamic shifts with a goal of tight, goal-directed fluid
therapy, knowledge of cardiac output (CO) and fluid responsiveness is important in the
perioperative period. The historical gold standard for evaluation of left ventricular end-
diastolic pressure (LVEDP), thermodilution (TD) uses a pulmonary artery catheter (PAC) to
generate a measured time/temperature curve, from which CO can be calculated. These
measurements are averaged over 2-9 minutes, so monitoring is not continuous. Recent studies
show that fluid management based on TD may not improve patient outcomes and may, in fact,
increase morbidity and mortality. PAC use itself may be complicated by arrhythmia, infection,
pulmonary artery rupture, and damage to right heart structures [63]. PAC use may be
unreliable due to the low pressure environment of the pulmonary vascular tree and the
interference by hydrostatic pressure. With pre-existent pulmonary hypertension PAC use may
become more reliable but conversely have more chance of a complication. The standard
deviation (SD) for TD is about 1 L/minute or about 20% of the average CO [64]. Clearly, reliable
and less-invasive methods of measuring CO are needed. Current options include lithium
dilution, esophageal Doppler monitoring (EDM), pulse contour cardiac output systems, partial
CO2 rebreathing, and thoracic electrical bioimpedance.
Two methods of generating continuous CO measurements require a central venous catheter
(CVC), which is arguably invasive, though less so than pulmonary artery catheterization.
PiCCO (PULSION Medical Systems AG, Munich, Germany) generates CO via thermodilution
from a CVC to a femoral or axillary arterial line. Using the Stewart-Hamilton principle, cold-
saline thermodilution is used to provide calibration of the continuous CO analysis. Similarly,
PulseCO (LiDCO Ltd, London, England) uses the Stewart-Hamilton equations as applied to
lithium chloride (0.15 - 0.3 mmol for an average adult) dilution from a CVC or peripheral vein
to an arterial line. The arterial lithium concentration-time curve can be subject to error in the
presence of certain muscle relaxants. Recalibration is recommended after changes in patient
position, therapy or condition. Clinical studies have demonstrated that over a wide range of
cardiac outputs the LiDCO method is at least as accurate as thermodilution [65, 66].
Esophageal doppler monitoring uses a continuous wave sensor on the end of a probe which
measures the velocity of blood flow within the descending thoracic aorta. Nomogram esti‐
mated aortic cross-sectional area based on the patient’s weight, height, and age enables
calculation of left ventricular (LV) stroke volume (SV) from the area of the velocity-time
waveform. The total time that blood is traveling in a forward direction within the area is the
systolic flow time, which is corrected for heart rate to give the corrected flow time, which is a
good index of systemic vascular resistance and is sensitive to changes in LV preload. There is
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positive correlation between measures of cardiac output made simultaneously with the
esophageal doppler and a thermodilution PAC [67]. Limitations of this monitor include
assumptions of the diameter of the aorta based on the weight and height of the patient, a
learning curve requiring about 12 probe placements [68], the need for patient sedation, and
inability to be used during esophagectomies. This method has good validation; however, it
only measures aortic blood flow and not true CO, and this may be potentially influenced by
disproportionate changes in blood flow between the upper and lower body, although this is
only important at the extremes of CO.
Pulse pressure (PP) methods measure the pressure in an artery over time to derive a waveform
and use this information to calculate cardiac performance. However, any measure from an
artery includes the changes in pressure associated with changes in vascular characteristics such
as compliance and impedance. Physiologic or therapeutic changes in vessel diameter seen in
the arterial waveform are assumed to reflect changes in CO. The ambiguity of the combined
results of CO and vascular tone limits the application of PP methods. The values obtained by
the LiDCOplus can be calibrated daily based on CO values generated by the LiDCO using the
CVC waveform. It can also be used independently, as with the FloTrac/Vigileo (Edwards
Lifesciences LLC, U.S.A.), which is an uncalibrated pulse contour analysis-based hemody‐
namic monitor that estimates CO utilizing a standard arterial catheter. The device consists of
a pressure transducer which derives left-sided CO from a sample of arterial pulsations using
an algorithm which calculates the product of the standard deviation of the arterial pressure
wave (AP) (over 20 seconds) and a vascular tone factor (Khi) to generate stroke volume. Khi
is derived from computer analysis of the morphologic change of the arterial pressure wave‐
forms on a bit by bit basis based on the principle that changes in compliance or resistance affect
the shape of the arterial pressure waveform. The equation in simplified form is as follows:
SV=std(AP) * Khi or BP x k(constant). CO is then derived utilizing the equation CO=HR*SV.
Only perfused beats that generate an arterial waveform should be counted for HR. While these
monitors do not require intracardiac catheterization with a pulmonary artery catheter, they
do require an arterial line. The benefits of this technology include the short time required for
set up and data acquisition.
Disadvantages include its inability to provide right-sided heart pressures or mixed venous
oxygen saturation. In addition, arterial monitoring systems are unable to predict changes in
vascular tone and can therefore only estimate changes in vascular compliance. Some consider
the measurement of pressure in the artery to calculate flow in the heart physiologically
oversimplified and of questionable accuracy and benefit [64, 69]. The sensor is only indicated
for adult use and has not been validated in patients with ventricular assist devices or intra-
aortic balloon pumps. Absolute values during aortic regurgitation may be affected although
trending may be appropriate. This monitor is dependent upon a high fidelity pressure tracing,
which is compromised by spontaneous ventilation, atrial fibrillation or ectopy, severe periph‐
eral constriction with vasopressor use, hypothermia, or dynamic autonomic states such as
sepsis. In those instances, femoral artery cannulation or insertion of a PAC may be considered.
Finally, in a study comparing these devices, although the PAC, FloTrac, LiDCO and PiCCO
display similar mean CO values, they trended differently in response to therapy and showed
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different interdevice agreement. In the clinically relevant low CO range (< 5 L/min), agreement
improved slightly. Thus, utility and validation studies using only one CO device may poten‐
tially not be extrapolated to equivalency of using another similar device [70].
The Fick principle allows multiple substitutions for O2 consumption, including CO2 clear‐
ance. Based on the ratio of the change in end-tidal CO2 (etCO2) and CO2 elimination, the
Noninvasive Cardiac Output (NICO) device (Novametrix Medical Systems, Inc., Walling‐
ford, CT, USA) calculates CO using a disposable rebreathing loop which allows intermit‐
tent partial rebreathing in 3 minute cycles. This system contains a CO2 sensor which uses
infrared light absorption, a disposable airflow sensor or differential pressure pneumotachom‐
eter, a specific disposable rebreathing loop, and a pulse oximeter. The production of CO2
(VCO2,  mL/min) is calculated from minute ventilation and its instantaneous CO2  content,
where the CaCO2 (mL/100 mL of blood) is estimated from etCO2 (mmHg). The rebreathing
cycle induces an increase in etCO2 and mimics a drop in CO2 production. CO2 production is
calculated as the product of CO2 concentration and air flow during a breathing cycle, and
the arterial content of CO2 (CaCO2) is derived from the etCO2 and the CO2 dissociation curve.
The  obtained  differences  of  these  values  are  then  used  to  calculate  CO,  such  that
CO=∆VCO2/(S x ∆etCO2),  where S is the slope of the CO2 dissociation curve. The NICO
system provides rapid, reliable CO values for mechanically ventilated patients with minor
lung abnormalities and stable ventilatory settings [71].
The NICO system is also limited. For example, intrapulmonary shunt can affect the estimation
of CO. Also, in patients undergoing thoracic surgery with OLV, the device underestimated
CO compared with thermodilution CO at all measurement times [72]. With worsening
pulmonary injury or hemodynamic compromise contributing to increasing shunt and dead
space, assumptions made for calculating CO are less likely to approximate actual values. This
technique reliably measures CO in patients affected by diseases causing low levels of pulmo‐
nary shunt, but underestimates it in patients with shunt higher than 35% [73]. In summary,
compared to TD methods, the partial CO2 rebreathing technique is non-invasive, can easily be
automated, and can provide real-time and continuous cardiac output monitoring. Large
outcome studies demonstrating use of this device are still lacking.
Impedance cardiography (ICG) or thoracic electrical bioimpedance (TEB) uses changes in
thoracic impedance over the cardiac cycle to generate CO. A constant magnitude, high
frequency, low amplitude current is applied longitudinally across a segment of thorax. Using
Ohm’s Law, the voltage difference within the current field is proportional to the electrical
impedance (Z). Contraction of the heart produces a cyclical change in transthoracic impedance
of about 0.5%. Upon ventricular ejection, a time-dependent cardiac-synchronous pulsatile
impedance change is observed, ∆Z(t), which constitutes the time-variable total transthoracic
impedance Z(t), when electrically parallel to baseline impedance (Z0). Lower impedance
indicates greater intrathoracic fluid volume and blood flow. TEB has waveform characteristics
representing points in the cardiac cycle. The first derivative (dz/dt) of the waveform is used to
identify the maximum upslope point, which is used to calculate the Velocity Index (VI). The
VI is indicative of aortic blood velocity, such that impaired contractility is reflected by a
decreased VI. By synchronizing fluid volume changes with the cardiac cycle, the change in
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impedance can be used to calculate SV, CO, and systemic vascular resistance [74]. TEB
equipment consists of both noninvasive and invasive devices, of which the former has gained
more acceptance. Examples include the Bio-Z Dx (Sonosite Inc®, Bothell, WA) and the
niccomo® (medis GmbH, Ilmenau, Germany). Some studies comparing TEB-derived CO to
TD have found significant correlation between the methods, but inaccuracies were observed
with severe tachycardia, low CO, or frequent arrhythmias [75]. Questions with respect to the
reliability and validity of this technique have led some to advocate its use only in research
settings [76]. The clinical use of TEB has yet to be established.
Transesophageal echocardiography (TEE) is a method of ultrasound-based cardiac imaging
which allows real-time visualization of anatomic structure and function. In the specific setting
of thoracic surgery, TEE can be used to monitor ventricular function, valvular function, and
wall motion changes reflective of ischemia during positioning changes, volume shifts, OLV,
or surgical resection. Intrathoracic tumors may be visible in some exams, and compression or
infiltration of structures such as the pulmonary artery or innominate vein may be visualized.
Tumor invasion of the heart may be appreciated, as can other anatomic abnormalities resulting
from the underlying disease process or iatrogenic causes. Intraoperative hemodynamic
instability of unknown cause and the need for evaluation of affected cardiac and pulmonary
structures will likely satisfy the Appropriate Use Criteria for Echocardiography [77]. Common
contraindications to TEE use include some features present in the thoracic surgery population
such as known esophageal strictures, perforation, lacerations or large diverticula. Relative
contraindications also obviate TEE use in esophagectomies: dysphagia or odynophagia, recent
upper GI bleeding, extensive radiation to the chest and mediastinum, and esophageal varices.
In terms of global cardiac function, the transgastric short-axis view provides a snapshot of left
and right ventricular ejection fraction. Calculation of CO is also possible with two-dimensional
(2D) Doppler measurements, such that CO = Aortic valve area (AVA) x heart rate (HR) x
velocity time integral (TVI). AVA may be measured by planimetry of the AV via the mideso‐
phageal AV short axis view, with the imaging plane at approximately 30°. Another common
method of calculating AVA is with the continuity equation, which states that the flow in one
area must equal the flow in a second area if there are no shunts between the two areas. In
practical terms, the flow from the left ventricular outflow tract (LVOT) is compared to the flow
at the level of the aortic valve:
Aortic Valve Area (cm2)= LVOT  diameter 2x  0.78540 x  LVOT  TV 1Aortic Valve TV 1
Where the CSA LVOT (cm2) = 0.785 x LVOT Diameter2
TVI is an integral of instantaneous blood flow velocities during one cardiac cycle. To measure
the LVOT TVI, the pulsed-Doppler sample volume is positioned just proximal to the aortic
valve so that the location of the velocity recording matches the LVOT diameter measurement.
When the sample volume is optimally positioned, the recording shows a smooth velocity curve
with a well-defined peak and narrow band of velocities throughout systole. The TVI is
measured by tracing the dense modal velocity throughout systole. The same is done for the
AV TVI.
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TEE assessment of cardiac and intrathoracic structures and function is a clinically established
method that plays a critical role in the diagnosis and management of perioperative hemody‐
namic instability in many institutions [78]. However, its main disadvantage is that its use
requires extensive training and a skilled operator [68]. Some measurements may be challenging
to acquire and subject to methodical error or inability to obtain images adequately parallel to
the ultrasound plane. Hemodynamic measurements obtained with TEE compared to TD with
a PAC have resulted in agreements ranging from good [79] to possessing “accuracy limita‐
tions” [80]. A significant source of this inconsistency may result from interoperator variability.
Further, in the instance of thoracic cases, proper contact with the stomach and esophagus in
the lateral position can hinder the acquisition of adequate images. Other inconveniences
include the expense of the equipment and the fact that an image cannot be easily fixed in order
to provide continuous cardiac output readings without the presence of an expert user.
In summary, the physiologic and hemodynamic challenges inherent to thoracic surgery may
require not only monitoring via an arterial wave pressure measurement, but possibly other
modalities as well. PAC, lithium dilution, EDM, pulse contour cardiac output systems, partial
CO2 rebreathing, TEB, and TEE constitute such alternatives. While validation of these methods
may be forthcoming, reasonable application of these modalities may improve perioperative
management and overall patient outcomes.
3.4. Special operative scenarios and anesthetic considerations
3.4.1. VATS versus open thoracotomy
The decision as to whether a particular surgery can be performed using a video-assisted
thoracoscopic or an open thoracotomy approach is a decision usually made by the surgeon. In
2007, at the International Society of Minimally Invasive Cardiothoracic Surgery conference,
evidence revealed that VATS can be recommended to reduce overall postoperative complica‐
tions, can reduce pain and overall functionality over the short term, improve delivery of
adjuvant chemotherapy delivery, and can be recommended for lobectomy in clinical stage I
and II non-small cell lung cancer patients. The recommendations were based on data derived
from single and multiple randomized studies, but with conflicting evidence and/or divergence
of opinion about the usefulness or efficacy of the procedure [81]. No general consensus using
multiple randomized clinical trials has been done as to the preference of surgical technique.
The bottom line is that with the learning curve for the VATS procedure, individual surgeons
choose their own preferred method of surgical intervention. The role of an anesthesiologist is
to be prepared for any lung surgery, both of which usually encompass one-lung ventilation,
either through a double-lumen tube or a bronchial blocker as a general anesthetic. A minor
VATS procedure such as pleural biopsy or thoracentesis can actually be done with local
anesthesia +/- intravenous sedation [82]. These procedures are rare in the operating room
however, and most VATS procedures are in actuality done under general anesthesia. An
endobronchial ultrasound is done at our institute in the pulmonary lab as a general anesthetic
with a laryngeal mask airway. Although a single-lumen endotracheal tube can be used under
general anesthesia for open thoracotomy, the operative lung field would also undergo positive
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pressure ventilation, making it technically more difficult for the surgeon. In small infants, a
balloon tipped bronchial blocker can be placed to isolate the lungmer[83] or placing ETT into
the mainstem of the nonoperative lung are also other options if a double lumen tube is too
large to be placed.
It is estimated that double lung tube placement has resulted in iatrogenic injury in 0.5-2 per
1000 cases of DLT placement[84], so care must be made to decrease these complications. One
advantage of a double lumen tube above a bronchial blocker is the ability to suction out the
operable lung if and when necessary, and increased intraoperative stability with the tube itself.
The bronchial blocker is often difficult to obtain lung isolation in the right lung due to the
takeoff of the right upper lobe being so close to the carina, but this technique is necessary to
understand in case a double lumen is unable to be placed (in patients with abnormal anatomy)
[85], or if a patient is already intubated with a single lumen tube with a difficult airway and
needs lung isolation. There have been a number of cases where both are used successfully
however. The key is having the lung isolated, and understanding physiology to understand
how to utilize hypoxic pulmonary vasoconstriction to each patient’s advantage.
In a thoracoscopic procedure, the surgeon does not have the ability to push the operative lung
out of his/her way like an open thoracotomy. Thus, the importance of the lung being deflated
is made apparent. Sometimes, a suction catheter can be placed in the operable lung to facilitate
deflation of the lung. It is important to know if the surgeon is to insufflate with carbon dioxide,
so that complications of insufflation can also be recognized. A VATS procedure is, although
for the patient sometimes easier to manage postoperatively, for the surgeon and anesthesiol‐
ogist comes with various difficulties. One of these difficulties has to do with not having enough
access or visualization in cases where the pulmonary artery or another major vessel is
inadvertently traumatized and the patient is bleeding. Therefore, it is always important to have
blood available for a possible blood transfusion in both open thoracotomies and VATS
procedures. An arterial line is necessary to keep a close eye on hemodynamics during both
types of procedures. The positioning for both usually entails a lateral decubitus position, and
pressure points must be checked. The postoperative pain level for patients with a thoracoscopic
procedure is usually less than the open thoracotomy patient though this has been questioned.
Chronic pain rates may be similar with VATS and open thoracotomies. A status post VATS
procedure patient can achieve pain control with IV medications, while an epidural is usually
recommended for thoracotomy patients. These methods of pain control will be discussed in a
later chapter.
3.4.2. Airway disruptive surgeries
Airway disruptive surgeries require special communication between the surgeon and anesthesi‐
ologist as to what is going to be required intraoperatively. With surgical and anesthetic advances,
now more than half the trachea can be safely excised in selected cases[86]. A tracheal resection
is something done rarely, requiring the anesthesiologist and surgeon to share the airway. The
type of anesthetic utilized depends on the skill of the anesthesiologist, and the experience within
each independent institution as to the best way to carry out this surgical procedure. There have
been many case reports depicting many different methods of maintaining oxygenation and
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ventilation for a patient while still undergoing a thoracic procedure that compromises the trachea
or bronchus. The main anesthetic concern is always adequate ventilation and oxygenation when
the airway is essentially open. It is also important to both the anesthesiologist and surgeon to
protect the integrity of the new tracheal anastomosis postoperatively. Steroids are often given
to help decrease airway edema. A high FiO2 is necessary to help maintain oxygenation during
periods of ventilatory pauses, but a close eye should be kept on electrocautery use. If indeed it
is being used, then the lowest FiO2 that the patient can tolerate should be kept to help prevent
airway fire. An arterial line is a good monitor to check for innominate compression (such as in a
medianstinoscopy) during surgical dissection.
A technique where a laryngeal mask airway is utilized with high-frequency jet ventilation for
a patient with tracheal stenosis has also been reported. In this otherwise healthy patient with
tracheal stenosis from prolonged intubation, an LMA was placed and the patient was put on
positive pressure ventilation. A sterile 6-mm flexible tube was placed in the distal trachea and
the patient adequately oxygenated/ventilated while the dissection and lesion was resected.
Once the tracheal anastomosis started, a jet ventilator was placed in the distal trachea and the
patient jet-ventilated for tracheal anastomosis. Once completed, the patient was once again
placed on positive pressure ventilation through the LMA while the patient was awakened,
found adequately spontaneously ventilating, and extubated successfully[87]. There are
disadvantages to using high-frequency jet ventilation such as during exhalation there may be
air trapping from the stenotic lesion, the catheter could become occluded by blood and
displaced, and there might be distal aspiration of debris or blood[88].
More routinely, an endotracheal tube can be placed above the area of stenosis. Once surgical
exposure is done, a separate tube can be placed distal to the stricture and the patient placed
on the ventilator with sterility across the field. Once the trachea is resected, the primary
endotracheal tube can be passed distal to the lesion and the anastomosis completed.
Another case has been reported in a patient with critical trachea stenosis. The patient under‐
went femoral-femoral extracorporeal bypass prior to induction. An endotracheal tube was
placed after induction, and the patient was maintained on the endotracheal tube and positive
pressure ventilation as he/she was weaned from the cardiopulmonary bypass machine[89].
A prospective study has been done in patients with upper tracheal stenosis that were managed
with a cervical epidural anesthesia, local anesthesia and conscious sedation while maintaining
spontaneous ventilation throughout the resection[90]. Although only twenty consecutive
patients were enrolled, the outcome had a high level of patient satisfaction and immediate
feedback from the patient throughout the procedure. This bypasses the need for jet ventilation
or positive pressure ventilation, and enables communication with the patient throughout the
surgical procedure.
Post resection, usually the patient is extubated with their neck in a flexed position to put less
tension on the anastomosis. Not infrequently the patients chin is sutured to the manubrium
sterni with a heavy stitch to maintain the flexion. A smooth extubation with minimal coughing/
bucking is preferred for the same reason. Extubation is important post operatively to reduce
the positive pressure on the suture line as well. Pain control is often not an issue, a tracheal
Principles and Practice of Cardiothoracic Surgery20
resection is not a very painful procedure, and intravenous narcotics and local anesthesia should
be adequate for control.
3.4.3. Endotracheal tube exchange (Double to single lumen tube exchange)
These days, double lumen tubes are routinely used for surgeries requiring lung isolation. If
extubation is unable to be accomplished at the conclusion of the surgery, the decision must be
made to either keep the double lumen in place, or exchange it for a single lumen tube. Less
than 1% of patients, however, require mechanical ventilation after surgery[91]. Exchanging
the double lumen tube avoids the potential obstruction of the airway that can occur when
secretions/blood get lodged in the bronchial tube. Also, the nursing staff that is to be taking
care of the patient postoperatively might not understand how to troubleshoot a double lumen
endobronchial tube, so misuse of the tube may occur including airway rupture.
Exchanging a double-lumen endobronchial tube to a single-lumen endotracheal tube has many
considerations and should be approached with some trepidation. An airway that was initially
easy to place the double lumen in might not be easyafter the surgery with volume shifts and
edema. If it is thought the airway might be lost in the exchange, leaving the double lumen in
overnight with the head of the bed elevated to help alleviate edema might be the safest option.
It has been shown that the flow resistances of modern double lumen tubes are actually much
lower than previously supposed, so the need to change them is not as important during
spontaneous ventilation and weaning from the ventilator as previously thought[92]. The
effective diameter of each lumen of an adult double lumen endobronchial tube is comparable
to a 6.0-7.0 mm outside diameter ETT [93], so adequate oxygenation/ventilation is manageable
without exchanging the tube. If an exchange is necessary, there are a few options described.
The first option is using a tube exchanger to facilitate the exchange of the double lumen tube
to a single lumen. First, adequate anesthesia and suctioning down both lumens of the double
lumen should be done. FiO2 should be 1.0. A tube exchanger is placed after being lubricated
through the tracheal lumen, both cuffs are deflated, and the double lumen is removed over
the stylet. A single lumen is then placed, sometimes while performing a direct laryngoscopy
to facilitate the exchange. There are other scenarios described using the Eschmann stylet as a
tube exchanger in various alternative ways [94]. The easiest and quickest method to exchang‐
ing the tube is just by performing a direct laryngoscopy after the patient is adequately
anesthetized. If visualization of the cords is easy while the double lumen is still in place, it can
be withdrawn and a single lumen placed under direct visualization.
Whichever technique is chosen, the safety of the patient comes first. If it is unsafe to change
the tube out, an alternative is to just pull out the double lumen so the bronchial cuff is in the
trachea, thus operating as a single lumen tube. Understanding that the airway anatomy and
ease of visualization might not be the same as it was preoperatively is very important. Certainly
it will not improve.
3.4.4. Post-operative need for bronchoscopy prior to emergence
Certain surgical scenarios may require fiberoptic bronchoscopic examination after completion
of the surgical procedure, but prior to patient emergence (if extubation is planned). These
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scenarios include the examination of the integrity of anastomotic sites, the examination of
anatomic structures (e.g.. the vocal cords) to ensure proper postoperative function, and the
clearing of debris (tissue, secretions, and blood) from the proximal and distal airways. During
fiberoptic bronchoscopic examination, the anesthesiologist must meticulously plan airway
control techniques to ensure an optimal environment for bronchoscopy as well as adequate
patient oxygenation and ventilation.
When a single-lumen endotracheal tube (SLT) is already in use, the procedure is usually
straightforward. If a bronchial blocker is used in combination with an SLT for lung isolation,
one simply removes the blocker from the SLT to facilitate fiberoptic bronchoscopy (broncho‐
scopy could also be performed with the blocker in place, if needed). However, one must keep
in mind that the internal diameter of the indwelling SLT must be large enough to accommodate
an appropriately sized bronchoscope, especially if adequate suction (provided by larger
bronchoscopes) is required to clear debris.
When a double-lumen endotracheal tube (DLT) is used for lung isolation, the procedure is
more complicated. Fiberoptic bronchoscopy with a DLT in place is difficult because of the
specialized tube’s design and required positioning. First, the internal diameters of the dual
lumens of the DLT are small. This limits the size of bronchoscopes that may be used (3.6 -
4.9mm outer diameter)—smaller bronchoscopes do not provide the view or possess the
suctioning capabilities of larger bronchoscopes. Second, DLTs are considerably longer and
more invasive than conventional SLTs. DLTs are positioned (post intubation) so that the distal
opening of the tracheal lumen closely abuts the primary carina with the distal bronchial end
placed in the appropriate mainstem bronchi (for which the DLT was designed). Therefore, a
properly placed DLT restricts direct bronchoscopic examination of a majority of the trachea
and mainstem bronchi. Comprehensive bronchoscopic examination in this scenario requires
removal of the DLT and subsequent replacement with an SLT or supraglottic airway device
(e.g. Laryngeal Mask AirwayTM - LMA North America, San Diego, CA, U.S.A.) in an anesthe‐
tized patient.
Supraglottic airway devices do not require endotracheal intubation and are preferred over
reintubation with an SLT because they [1] reduce the possibility of trauma to fresh surgical
anastomosis  sites  within  the  airways,  [2]  improve  the  visualization  of  proximal  airway
structures – vocal cords, proximal trachea – that would be otherwise obstructed by SLTs, [3]
accommodate larger bronchoscopes for improved visualization and suctioning, and [4] are
less complicated to place than SLTs and do not require neuromuscular blockade for easy
placement.  In  patients  with  non-difficult  airways,  supraglottic  airway  devices  may  be
immediately  placed after  deep extubation (in  a  blind fashion).  In  patients  with  difficult
airways, supraglottic airway devices may be pre-positioned posterior to the DLT prior to
extubation. This allows for fiberoptic visual confirmation of the device’s proper position‐
ing (by continuous visualization of the glottic opening) prior to, during, and after extuba‐
tion.  Once  positioning  of  the  supraglottic  airway  device  and  adequate  ventilation  are
confirmed,  fiberoptic  examination of  the airways may proceed.  Upon completion of  the
bronchoscopic exam, the patient may be emerged from anesthesia with the device in place
without the need for reintubation.
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3.4.5. Pulmonary procedures in out-of-O.R. settings
A trend is growing toward performing pulmonary procedures in specialized non-O.R.
pulmonary procedure suites, rather than the traditional operating room. These procedures
may be performed for diagnostic or therapeutic purposes and include flexible/rigid broncho‐
scopy, pleuroscopy, tracheo-bronchial stent placement or dilation, and endobronchial ultra‐
sound-guided lymph node sampling [95]. In these settings, special anesthetic considerations
must be made regarding choice of agents, airway devices, and ventilatory modes.
a. Agents
A total intravenous anesthetic (TIVA) approach is the most practical mode of anesthetic
delivery in these settings. A TIVA-based approach avoids volatile anesthetic agents that could
be lost from airways in procedures that involve a breach of the airway (and/or the airway
device). Loss of agent through a breach could result in inadequate anesthetic levels, exposure
of personnel to volatile agents, combustion and airway fire (N2O), or production of toxic
products after pyrolysis. Furthermore, special ventilatory modes (such as jet-ventilation)
necessary for certain pulmonary procedures preclude the use of volatile anesthetics [96].
Two anesthetic challenges during pulmonary procedures are [1] providing adequate anesthe‐
sia during alternating periods of high and low stimulation (in which anesthetic requirements
also fluctuate rapidly), and [2] rapid recovery post-procedure [96]. The intravenous agents
propofol, remifentanil, and lidocaine have specific advantages in these situations, primarily
as a result of their pharmacokinetic/pharmacodynamic profiles. The standard sedative-
hypnotic for TIVA administration is propofol, and, in fact, propofol is the only sedative-
hypnotic that is used on a standard basis for continuous infusion. Only propofol has the
combination of quick onset, short half-life, rapid redistribution, amnesia, effective airway
reflex depression, wide anesthetic depth range, and antiemetic properties. It does not,
however, provide analgesia; therefore, narcotics are usually added to a TIVA regimen.
Narcotics provide analgesia, reduce the propofol dosage needed, and also suppress the cough
reflex. Remifentanil is an ultra-short acting narcotic (context sensitive half-life: 3-5 minutes)
that is metabolized by nonspecific tissue and plasma esterases; therefore, it is ideal intraoo‐
peratively to manage moments of high stimulation while avoiding over-accumulation of
narcotic when stimulation subsides [97]. In patients for whom post-procedure pain control or
cough suppression is needed, a longer-acting narcotic may be coadministered with remifen‐
tanil. Lastly, intravenous lidocaine is a useful adjunct to propofol and remifentanil in TIVA.
Lidocaine is an amide-type local anesthetic that reduces the need for both propofol and
narcotics; it also suppresses airway reflexes and is an effective post-procedure anti-tussive [98].
b. Airway devices
Airway management for pulmonary procedures must address the need for adequate patient
oxygenation/ventilation, permit complete examination of areas of interest of the airway, and
accommodate the necessary diagnostic and/or interventional instruments needed for the
procedure. In most cases, supraglottic airways (e.g., Laryngeal Mask AirwayTM) meet these
requirements and are the airway devices of choice. They are easy to place without the need for
specialized equipment, are an integral part of the standard difficult airway algorithm, may be
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used in spontaneously or mechanically ventilated patients, and provide limited airway
protection from regurgitation. Furthermore, supraglottic airways may be easily used as a
bridge in a case where definitive airway control will be managed via rigid bronchoscopy/jet-
ventilation. In such a case, the supraglottic airway is placed as a temporary airway conduit
during induction, is removed once the rigid bronchoscopy begins, and is replaced at the end
of the procedure to serve as the airway conduit until emergence from anesthesia.
c. Ventilatory modes
Patient ventilation/oxygenation during pulmonary procedures may be spontaneous or
mechanical, depending on the requirements of the procedure. Adequacy of oxygenation and
ventilation is measured by pulse oximetry and end-tidal CO2 measurement. It is important to
note that while end-tidal CO2 detection is vital in confirming adequate ventilation, it is often
inconsistent due to airway breach and suctioning inherent during pulmonary procedures. Of
the various mechanical ventilation modes, jet-ventilation deserves particular attention. Jet-
ventilation is typically associated with rigid bronchoscopy. In this situation, total airway
control will be in the hands of the interventionalist/surgeon, with the anesthesiologist con‐
trolling the jet-ventilator. Control of jet ventilation may be by automated jet delivery systems
or manually by the anesthesiologist. Automated systems have several benefits over manual
delivery, including greater control of delivered FiO2 and respiratory frequency, duration, and
flow. Additionally, automation gives anesthesia personnel greater freedom to attend to other
aspects of the anesthetic care.
3.4.6. Post anesthesia recovery considerations for patients undergoing thoracic procedures
The immediate post-operative care of the thoracic surgical patient is focused on ensuring
conditions that optimize oxygenation/ventilation and recognizing possible post-operative
complications inherent to thoracic surgery.
a. Extubation
If feasible, immediate post-operative extubation is favored to avoid unnecessary hemody‐
namic stress, the disruption of fresh surgical sites from continued intubation, positive-pressure
ventilation, and/or coughing, and the development of ventilator-associated pneumonia [99].
However, the tentative respiratory condition of the typical thoracic surgery patient warrants
careful consideration when making the decision to extubate (see preoperative anesthetic
evaluation above). The physician must not only optimize routine respiratory criteria for
extubation – pH ≥ 7.30, FiO2 ≤ 0.4-0.5, PaO2/FiO2 > 150-200, PEEP ≤ 5-8 cmH2O, RR ≤ 30 bpm,
SpO2 ≥ 90%, PaO2 ≥ 60, PaCO2 ≤ 50, Vt > 5 ml/kg, VC >15 ml/kg, NIF > -20 cm H2O – but must
also recognize the variable nature of emergence from anesthesia and consider the state of other
important clinical variables [100]. These variables include the ability to follow commands, the
return of airway protective reflexes, adequate reversal of neuromuscular blockade (with good
motor strength), adequate pain control, normothermia, hemodynamic stability, and normal
electrolyte values. Additionally, the rapid shallow breathing index (RSBI - the ratio of respi‐
ratory frequency to tidal volume (f/VT)) combines superior sensitivity (97%) and negative
predictive value (95%) when predicting weaning success [101, 102].
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Once extubation is achieved, the focus is on optimizing pulmonary physiology; three funda‐
mental measures are essential. First, supplemental oxygen should be administered and
adequate ventilation confirmed, because hypoxia and hypercarbia are well known to increase
pulmonary vascular resistance [103]. Second, the patient should be positioned supine with the
head of the bed elevated (semi-Fowler’s position) to lessen the risk of aspiration and decrease
the work of breathing. Third, pain control must be evaluated; pain increases sympathetic tone,
elevating pulmonary artery pressures and pulmonary vascular resistance, and elicits respira‐
tory splinting that limits ventilation and results in hypercapnea.
In some cases, continued intubation and mechanical ventilation is required postoperatively.
Under these circumstances, it is important to achieve the transition from positive pressure to
spontaneous ventilation as quickly as possible. In addition, extubation criteria should be
assessed frequently so that extubation may be acheived as soon as possible.
b. Post-operative Complications
Operations involving vital thoracic structures place patients at higher risk of life-threatening
post-operative complications. An in-depth discussion of these complications can be found in
chapters detailing the post-operative course of these patients. This section focuses on select
complications that may occur in the immediate post-operative recovery period: injuries in the
conducting airways, pneumothorax, and cardiac herniation.
i. Injuries in the conducting airways
Advanced anesthetic airway management and surgical manipulation predispose the thoracic
surgery patient to a variety of post-operative airway complications. Injuries range from
erythema/edema (most commonly) to vocal cord injuries and tracheo-bronchial rupture (TBR)
(rarely). Supportive therapy with supplemental humidified oxygen is adequate for mild
symptoms of airway edema; however, constant monitoring for worsening respiratory ob‐
struction is paramount. Iatrogenic vocal cord injuries resulting from intubation and/or damage
to the recurrent laryngeal nerve may lead to airway compromise and increase risk of aspiration,
if the damage is bilateral. Dyspnea, stridor, and inability to phonate are symptoms commonly
associated with bilateral vocal cord injury/paralysis. If respiratory distress is present, the
airway should be definitely controlled via intubation or tracheostomy. TBR caused by DLT
intubation is extremely rare, with a reported incidence of less than 0.5 % [84]. Hemoptysis and
subcutaneous crepitus (in the neck and upper chest area) are the most common presenting
symptoms with respiratory distress and/or collapse occurring in advanced cases [104]. If TBR
is suspected and surgical intervention planned, general anesthesia should be induced while
preferably maintaining spontaneous ventilation to avoid worsening of the injury by barotrau‐
ma. Initial airway control with a supraglottic airway is preferred, when possible, to avoid
further injury that can occur with endotracheal intubation. Further, a supraglottic airway
allows for complete fiber-optic examination of the trachea, bronchi, and distal airways. Fiber-
optic examination of the tracheobronchial tree is important to confirm the diagnosis of TBR
and to locate the lesion. Once the location and extent of the injury is determined, the type and
application of airway control may be chosen and surgical repair undertaken. In extreme
situations, cardio-pulmonary bypass may be required to assure oxygenation and ventilation.
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ii. Pneumothorax
Pneumothorax is a potentially grave immediate postoperative complication that may neces‐
sitate prompt intervention. The creation of a pneumothorax is inherent in any procedure
involving the breach of the thoracic cavity. The severity of pneumothorax is determined by its
magnitude and whether it is in communication externally with atmospheric pressure. A
pneumothorax of small volume is usually well tolerated; however, with increased magnitude,
it exerts considerable effects to the heart and vasculature in the confined space of the thoracic
cavity. These may lead to hemodynamic collapse and respiratory compromise – a tension
pneumothorax. Chest drainage tubes are used to decrease the magnitude of a pneumothorax
by providing an avenue of escape for trapped air (and/or blood, secretions, etc.) from the
thoracic cavity. Specialized “balanced” drainage systems have been developed for certain
operations, such as pneumonectomy. Balanced systems provide a buffer to prevent excessive
negative or positive intrathoracic pressures from developing, lowering the chance for both
tension pneumothorax and cardiac herniation (see below) [105]. In circumstances where chest
tubes are not placed or where the drainage system malfunctions, tension pneumothorax may
develop. In this scenario, intrathoracic pressures must be relieved immediately via needle
decompression and/or emergent chest tube insertion. One must recognize that contralateral
pneumothorax is also a possibility from anesthetic (contralateral central venous catheters,
epidural (paramedian) placement, barotrauma) as well as surgical (breach of the contralateral
pleura) insult [106]. Care must be taken to avoid clamping chest tubes after thoracotomy to
avoid formation of a pneumothorax.
iii. Cardiac herniation
Cardiac herniation, although rare, is a potentially fatal postoperative complication most
commonly associated with disruption of the pericardium – most commonly during the course
of or after a pneumonectomy. The usual presenting symptoms are generalized hypotension
and tachycardia; however, right versus left sided cardiac herniation may present with
additional distinct signs and symptoms inherent to the physiologic disruption unique to the
direction of herniation [107, 108]. Leftward herniation places the heart at risk for myocardial
ischemia and arrhythmias, because of the potential constriction of the ventricles by pericardial
tissue during the course of the herniation [107, 108]. Rightward herniation predisposes the
patient to superior vena cava (SVC) syndrome – head, neck and upper-extremity cyanosis,
edema, etc. - secondary to torsion and obstruction of the SVC and inadequate cardiac preload
because of impaired venous drainage [107, 108]. After assessing signs and symptoms, cardiac
herniation may be confirmed via imaging - chest x-ray and/or echocardiography. Immediate
surgical intervention to reduce the herniation and correct the pericardial defect is paramount
to prevent further hemodynamic collapse [107, 108]. The gravity of cardiac herniation warrants
recovery measures to help minimize its occurrence. Avoid patient positioning with the
operative side dependent, to reduce gravitational effects favoring herniation. As discussed
above, early extubation is favored to alleviate the effects of positive pressure ventilation and
its tendency to instigate and worsen herniation. Lastly, avoid negative pressure via chest
drainage tubes (preferably using balanced chest drainage systems in pneumonectomies) to
minimize a vacuum effect that may predispose to herniation [107, 108].
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4. Pain management for the thoracic surgical patient
4.1. Post-thoracotomy pain syndrome
Thoracotomies continue to cause substantial pain because of the degree of surgical injury.
Insult to the intercostal nerves, soft tissue damage and inflammation, bone and joint disturb‐
ance, and visceral manipulation all contribute to the severity of pain[88]. The estimated
incidence of chronic pain following thoracotomy is between 30-40%, with approximately 10%
with severe disabling pain [109, 110]. Pain control is crucial after thoracic surgery not only for
immediate pain relief, but also to prevent pulmonary complications.
“Pain that recurs or persists along a thoracotomy scar at least two months following the
surgical procedure” [111] is the definition of post-thoracotomy pain syndrome (PTPS). Poor
pain management after thoracotomy may contribute to PTPS [112]. The pain is largely
described as aching, with tenderness and numbness at or around the surgical incision/scar
[113]. In contrast to acute pain, which mostly affects respiratory function, PTPS may be
responsible for inability to perform daily activities. Although PTPS likely plays a negative role
in daily life, its impact is unclear because these subjective phenomena have not been reliably
assessed [113, 114].
Although video assisted thoracic surgery (VATS) was anticipated to reduce pain when
compared to traditional posterolateral thoracotomy, its smaller port sites do not necessarily
avoid intercostal nerve injury owing to aggressive manipulation of the scopes and instruments.
The pain associated with VATS is not significantly different to that of thoracotomy[115] and
there are conflicting differences in the incidence of PTPS [113, 114]. It is unclear if patients with
preventative analgesia by way of thoracic epidural analgesia have fewer propensities to
develop PTPS [114]. Other regional techniques have not yet been studied in this capacity [114].
There is also conflicting evidence of the causality of acute pain on PTPS [114].
There are many modalities of postoperative pain control that will be briefly explained here.
4.2. Systemic analgesics
Opioids have a long-standing history of providing effective pain relief. It is the unwanted side-
effects that discourage their use including: nausea, vomiting, respiratory depression, ileus,
biliary spasms, urinary retention, sedation, and pruritis. Opioids can be given by many routes
– oral, intravenous, intramuscular, transdermal, transmucosal. Intravenous patient controlled
analgesia (PCA) allows for increased safety, less opioid use, ability to titrate to individual
needs, and some increase in patient satisfaction [116]. Using opioids alone may lead to
intolerable side effects, which has led to the concomitant use of other drug classes for their
synergistic effects.
Ketamine is an N-methyl-D-aspartate (NMDA) antagonist that has direct spinal effects as well
as depresses the thalamus and activates the limbic system. It acts at the phencyclidine binding
site and has been used as an induction agent. At lower doses, it provides effective analgesia.
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The use of low dose intraoperative ketamine offers decreased postoperative pain and mor‐
phine consumption [117, 118].
Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit conversion of arachidonic acid to
prostaglandin E2 in inflamed areas via cyclooxygenase (COX). It is suggested that the maxi‐
mum daily dose of NSAIDs should be given/ordered because small doses of NSAIDs are not
useful in acute pain relief [118]. When given in conjunction with opioids, NSAIDs reduced the
postoperative opioid utilization and decreased unwanted opioid side effects [118]. NSAIDs
should be used cautiously in those susceptible to its side effects including risk of renal injury,
bleeding and peptic ulcers, asthma and bronchospasm. COX-2 selective inhibitors were
developed to avoid the unwanted side effects of NSAIDs and may play a role as an adjunct in
postoperative pain control.
4.3. Thoracic epidural
Thoracic epidural refers to analgesic technique of injecting medication into the epidural space,
the potential space that surrounds the spinal cord. A segmental block results with coverage
both above and below the injection site. A single injection into the epidural space may be
performed, or a catheter may be inserted for prolonged infusion. For post-thoracotomy pain
relief, commonly a catheter is inserted via midline or paramedian technique in order to provide
intermittent boluses as well as a continuous infusion for pain control. Infusions usually consist
of a local anesthetic, an opioid, or a mixture of the two in order to optimize their synergistic
effects [119] while reducing the individual doses and side effects [119, 120]. As the nerve roots
leave the foramen and become peripheral nerves, they cross through the epidural space where
they are bathed in the epidural solution.
The mechanism of action differs between local anesthetics and opioids. Local anesthetics block
sodium channels ultimately leading to blocked nerve conduction. The density of local
anesthetic blockade is primarily dependent on the concentration of local anesthetic present,
and dermatomal spread of blockade is dependent on the volume infused. Also remember that
the level of somatic block may be smaller than the sympathetic block because the somatic fibers
are less sensitive [121]. Opioids bind to presynaptic and postsynaptic opioid receptors in the
substantia gelatinosa, which inhibits the presynaptic release and postsynaptic response to
neurotransmitters [121]. In a systemic review of randomized trials, Joshi et al. found that
patients with thoracic epidural analgesia had a significantly lower pain scores and needed less
supplemental analgesia compared to systemic opioid analgesia [122].
Adverse effects may be from various aspects of epidural placement. Those associated with
needle and catheter placement include back pain, inadvertent dural puncture, post dural
puncture headache, trauma to spinal cord or nerves, and neuropathy (usually transient). Dural
puncture may lead to post dural puncture headache. The headache is usually characterized by
severe fronto-occipital pain with head elevation that subsides, sometimes completely, upon
return to the supine position [88]. The loss of CSF through the small puncture site may be
enough to cause traction on the brain causing pain. Most patients’ symptoms completely
resolve after a few days to a week. Those that are not able or not willing to wait for spontaneous
resolution may opt to undergo an epidural blood patch. Neurologic injury may be the most
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feared complication of epidural analgesia. Nerve injury is usually transient and may occur
from direct trauma to the nerves or spinal cord during needle insertion. A more devastating
nerve injury can result from an epidural hematoma or abscess. Spinal hematoma occurs very
rarely, approximately less than 1 in 150,000 [88]. Although rare, if it is not detected and treated
promptly, it leads to irreversible paraplegia. The occurrence of hematoma has been on the rise,
whether it is from increased coexistence of anticoagulation and regional anesthesia technique
or from increased reporting [123]. Infection can occur from ineffective sterile preparation,
contaminated drugs, an underlying infection, or bacteremia. Any of these sources can cause
an infection at the insertion site or lead to spread of infection from the skin along the indwelling
catheter into the epidural space causing meningitis (if the dura was punctured) or abscess
which could ultimately result in cord compression [123].
Effects related to epidural injection of local anesthetic are usually dose related and include
hypotension, motor block, systemic toxicity, and urinary retention. Epidural opioid adminis‐
tration may result in adverse effects that are similar to their parenteral administration. These
include pruritis, nausea, urinary retention, decreased arousability, ileus, and respiratory
depression. Respiratory depression is the most concerning of the adverse effects and thus
necessitates a monitored setting. After epidural injection, in the following 2-4 hours, early
respiratory depression can occur which is likely due to the systemic absorption of the opioid
[124]. Some opioids are more hydrophilic than others and have a tendency to remain in the
CSF causing possible spread and delayed respiratory depression (usually occurs after 4 hours).
Relative contraindications to epidural include sepsis or bacteremia, infection at the insertion
site, hypovolemia or shock, coagulopathy or thrombocytopenia, increased intracranial
pressure (for risk of brain herniation if accidental dural puncture). One should use caution
with patients who have underlying neurological diseases as not to confuse effects of the
epidural versus pre-existing neurological deficits. The only absolute contraindication to
epidural placement is patient refusal [88].
4.4. Thoracic paravertebral nerve block
TPVB involves injecting local anesthetic into the space adjacent to the thoracic vertebrae, which
contains the spinal intercostal nerves. The boundaries of the space include the parietal pleura
anterolaterally, the superior costotransverse ligament posteriorly, and medially by a portion
of the vertebral body, intervertebral disc and intervertebral foramen [125]. The paravertebral
space is continuous with the epidural space, intercostal space, and contralateral paravertebral
space (by way of the prevertebral and epidural spaces). The caudal boundary of the space is
at the origin of the psoas, while the cranial boundary is unknown. Cranially, radiographic dye
has been noted after a thoracic paravertebral injection in the cervical area [126]. The intercostal
nerves, dorsal rami, sympathetic chain and associated vessels lie within the fat of the para‐
vertebral space [126]. A percutaneous technique is classically described whereby a needle is
inserted into the space until a subtle loss of resistance is met followed by aspiration to ensure
that the lung or pleura has not been breached before injecting small amounts of local anesthetic
or insertion of a catheter [125]. The injection of local anesthetic can also be performed under
direct visualization by the surgeon prior to the closure of the chest wall.
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Injection of local anesthetic into the paravertebral space can give varying degrees of analgesia.
The injection may remain localized to the area of injection producing a single level ipisilateral
block, or it can spread to the above and below adjacent levels, as well as to the epidural space
and contralateral paravertebral space. For example, Eason found that a single injection of 15ml
of 0.375% bupivacaine spread over 4 spaces [125]. Similarly, 15ml of 0.5% bupivacaine injection
led to a unilateral 5 level dermatome somatic block and 8 level sympathetic block [127].
Advantages of TPVB are many. TPVB is easy to learn and has a high success rate [126].
Successful placement of TPVB also can eliminate some unwanted effects of epidural analgesia
such as spinal cord injury, spinal hematoma, excessive hypotension (owing to only a unilateral
sympathetic blockade), and urinary retention [128]. Also, the nursing care required after TPVB
is no different than normal post-surgical care [129]. A meta-analysis identified TPVB as having
equivalent pain relief after thoracic surgery with less major side effects and decreased
pulmonary complications to that of epidural analgesia [130].
Adverse effects of TPVB include accidental pleural puncture, which could lead to a pneumo‐
thorax. The incidence of puncture and pneumothorax are 0.8% and 0.5% respectively, which
is similar to other anesthetic procedures with pneumothorax risk [128]. Other adverse effects
include relative hypotension, failed block, and vascular puncture.
Contraindications to TPVB are similar to those of epidural placement including infection at
the insertion site, bacteremia, epyema. Another relative contraindication would be if the
patient has had a previous thoracotomy because the ipsilateral paravertebral space may have
been altered or obliterated as a result of surgery [124]. With respect to anticoagulation, the
paravertebral space is less vascular than the epidural space, and paravertebral vessel puncture
is less common [128, 129].
4.5. Intercostal nerve block
The intercostal nerve provides sensory and motor innervation to chest wall and is found in the
costal groove of each rib. Intercostal nerve blockade provides unilateral sensory and motor
anesthesia to these areas. Local anesthetic is commonly injected 5 to 7 cm from the midline
over several sections owing to the great deal of overlap between the intercostal nerves. There
are different approaches to intercostal nerve blocks for thoracic procedures. The simplest is to
inject local anesthetic around several intercostal nerves during thoracotomy when the chest
wall is open. Cryotherapy, continuous infusion or successive boluses of local anesthetic are
also options [131].
Direct intercostal nerve block is most easily done by direct visualization during thoracoto‐
my, but can also be done percutaneously. Local is injected over multiple segments inferior
to the rib with caution to avoid intravascular injection. Usually a small amount (2-5ml) of
local  is  injected  two to  three  spaces  above  and below the  incision  [131].  Cryoanalgesia
interrupts nerve conduction for 1 to 3 months as a result of the freezing and subsequent
damage of the myelin sheath [131] and is associated with long term intercostal neuralgia
[132]. Extrapleural and interpleural infusion of local anesthetic are also techniques to block
the intercostal nerves. Peeling back the pleura from the chest wall can create an extrapleu‐
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ral pocket, and a catheter can be introduced percutaneously into the space. After closure
of the thoracotomy, an infusion of  local  anesthetic  will  fill  the extrapleural  space which
leads to an intercostal block. Interpleural catheters can be inserted percutaneously to attain
an intercostal nerve block, but one must keep in mind that a large volume of the anesthet‐
ic may be lost to the chest tubes. Interpleural anesthesia requires diffusion across the pleura
and sub pleural space in order to attain an intercostal nerve blockade. Single shot direct
intercostal  nerve  block appears  to  have  the  same or  superior  pain  control  compared to
epidural  on  the  day  of  surgery,  but  after  the  effects  of  the  local  anesthesia  have  been
exhausted, epidural anesthesia is superior to intercostal nerve block [131-133] Detterbeck
states that extrapleural infusion of local anesthetic is more effective than systemic narcot‐
ics,  and  at  least  as  good  as  thoracic  epidural.  Extrapleural  intercostal  nerve  block  pro‐
vides  a  unilateral  blockade,  so  the  amount  of  urinary  retention  and  hypotension  are
decreased, and there is not a need for special monitoring because the risk of respiratory
depression is minimal [131]. Pain relief from interpleural infusion is inconsistent [131].
Systemic absorption of local anesthetic is notoriously high for intercostal nerve block due to
the vascularity of the area of injection. There are no specific absolute contraindications to
intercostal nerve blocks. They should be avoided in patients in whom high systemic levels of
local anesthetics will not be well tolerated such as those with seizure disorders.
4.6. Elastomeric pumps
Wound infiltration with local anesthetic targets the peripheral level of pain, and has been used
widely in minor surgical procedures [134, 135]. The relatively short-term duration of the local
infiltration limits the usefulness of one-time wound infiltration for more major thoracic
surgery. An elastomeric pump connected to a multi orifice catheter allows for continuous local
anesthetic incisional infusion. Implementation of this technique is quite simple, with a minimal
technical failure incidence [116]. A catheter is threaded in or near the insult and connected to
a reservoir pump of local anesthetic by way of a flow-limiting valve. The surrounding tissues
are then continuously bathed in the local anesthetic at 4ml/hr. By providing anesthesia at the
site of insult there may be less need for systemic narcotics, and avoid many systemic narcotic
effects including postoperative nausea and vomiting. It is also believed that local anesthetic at
the wound site can decrease the local inflammatory response which may in turn decrease pain
and hyperalgesia [116]. Wheatley et al found that using an elastomeric pump is a safe and
effective adjunct for post-thoracotomy pain relief. Also, patients had lower pain scores and
decreased narcotic need when compared to thoracic epidural analgesia alone [136]. Although
local anesthetic toxicity is always a concern with infusions, the incidence of systemic toxicity
is low [116]. Wound infiltration is safe and not associated with increased acute wound-related
complications or long-term effects on wound healing [137].
4.7. Anticoagulation
Hemorrhagic complications from neuraxial blockade are of great concern. Epidural analgesia
is usually not initiated in patients who have a preexisting coagulopathy. The following are
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some consensus guidelines assembled by the American Society of Regional Anesthesia and
Pain Medicine [138]:
1. Thrombolytic therapy
• Avoid thrombolytic for 10 days after neuraxial puncture,
• It is not clear how long to wait after thrombolytic therapy for safe performance of neuraxial
anesthesia,
• If neuraxial block is at or near time of thrombolytic therapy neurologic checks should be
none no less than every 2 hours,
• There is no recommendation for removal of neuraxial catheters in unexpected thrombolytic
therapy
2. Subcutaneous unfractionated heparin
• Review of other medications that may affect clotting is advised
• There is little risk of spinal hematoma
• Placement of the block prior to therapy may be desirable although increased risk is not
demonstrated in the presence of subcutaneous heparin
• In twice-daily doses – epidurals may be placed before the next scheduled dose, the catheter
can coexist with regimen, and preferably the catheter can be removed one hour prior to next
dose
• Thrice daily doses or more than 10,000units unfractionated heparin – there is no data
published, but it is advised not to maintain an epidural catheter with this regimen
• If the patient has received more than four days of heparin, a platelet count should be
obtained prior to block or removal of catheter in the instace of heparin induced thrombo‐
cytopenia
• After needle placement, wait one hour to administer heparin
• Wait 2-4 hours after heparin to remove cathers, resume therapy one hours after removal of
catheter
• Bloody placement may increase risk of hematoma, but the case does not necessarily need to
be cancelled.
3. Low-Molecular Weight Heparin
• A bloody placement does not mandate cancellation of the case, however LMWH should be
delayed for 24 hours
• Epidural placement should happen 10-12 hours after last does
• If the patient is on higher dose LMWH, one should wait 24 hours to place epidural
• Do not place epidural at 2 hours after dose – peak anticoagulation activity
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• Twice daily doses should not be initiated with an indwelling catheter, and must be removed
before the first dose
• Once-daily dosing – may start 6-8 hours postoperatively, the catheter can be maintained,
removal after 10-12 hours of last dose
4. Oral Anticoagulants – Warfarin
• INR should be normalized prior to neuraxial technique
• If initial does of warfarin is given more than 24 hours prior to surgery, INR should be
checked prior to neuraxial block
• If low-dose warfarin therapy is ongoing during epidural anesthesia, neurological evalua‐
tions and daily INR checks are advised
• Catheters should be removed when INR is less than 1.5, and neurological assessment should
be continued for 24 hours
• If 1.5 < INR < 3, catheters should be cautiously removed
• If the INR is more than 3, the dose of warfarin should be held/reduced
5. Antiplatelet Medications
• NSAIDs have no specific concerns or added risk with epidural with or without catheter
placement, unless concurrent medications affecting clotting
• The risk of bleeding with clopidogrel, ticlopidine, and GP IIB/IIIA inhibitors is not known.
• 7 and 14 days should elapse between discontinuation of ticlopidine and clopidogre,
respectively, and placement of neuraxial block
• Platelet function normalization must occur before placement of neuraxial block if discon‐
tinued for only 5-7 days
• Epidural catheters should not be maintained while on GP IIB/IIIA inhibitor therapy
6. Herbals
• They do not create risk that impedes with neuraxial block
• Garlic inhibits platelet aggregation, increases fibrinolysis
• Ginko inhibits platelet-activating factor
• Ginseng has the potential to inhibit coagulation
7. Thrombin inhibitors
• Monitored by aPTTT
• Anticoagulation effect present for 1-3 hours
• There are no pharmacologic reversals
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• Neuraxial techniques are best avoided
8. Fondaparinux
• Factor Xa inhibitor
• Unknown risk of spinal hematoma
5. Conclusion
The challenges of thoracic anesthesia are unique among all anesthetic subspecialties. Its
practitioners must be well-versed in a wide range of anesthetic management principles, from
advanced airway techniques to ventilations strategies and pain management. The two
subspecialties of thoracic surgery and thoracic anesthesia continue to co-evolve to improve
patient safety and surgical outcomes.
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